| abstract |
tyrosine kinase inhibitors the present invention provides compounds and their pharmaceutically acceptable salts that are tyrosine kinase inhibitors, in particular blk, bmx, egfr, her2, her4, itk, tec, btk and txk and are therefore useful for the treatment of diseases treatable by inhibiting tyrosine kinases such as cancer and inflammatory diseases such as arthritis, and the like. also provided are pharmaceutical compositions containing such compounds and their pharmaceutically acceptable salts and processes for preparing such compounds and their pharmaceutically acceptable salts. |